Winning stocks for the Oracle of Omaha were few during the first six months of the year.
News & Analysis: Teva Pharmaceutical Industries
Turnaround stories really do exist on Wall Street.
These are the stocks that might power one Fool's portfolio higher for the remainder of the year.
Emergent BioSolutions has become the go-to manufacturing partner for companies looking to develop vaccines for the coronavirus.
It's a face-off between an incredibly cheap stock and a pharmaceutical giant.
There are some serious bargains in Berkshire Hathaway's investment portfolio, as well as a few land mines.
FDA Revokes Emergency Use Authorization for Hydroxychloroquine and Chloroquine as COVID-19 Treatments
The agency found no evidence to support the theory that the antimalarial drugs touted by President Trump are effective against the coronavirus.
Even with a 40% bounce off of the stock market's lows, these companies still offer incredible value.
Here's why a new initiative by the FDA to reduce drug prices is great for patients but should raise the alarm among pharmaceutical investors.
One of them still looks like a great pick to buy.